WashU Cardiovascular Division faculty members Mark Huffman, MD, MPH and Zainab Mahmoud, MD, MSc, along with cardiology fellow Aishwarya Vijay, MD, have published a perspective in Circulation addressing implementation of the newly released 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome.
The article, titled“2026 Cardiovascular-Kidney-Metabolic Guidelines: Practical Implementation Strategies,” examines opportunities and challenges associated with translating the landmark guideline into routine clinical practice. The first-of-its-kind guideline recognizes the interconnected nature of cardiovascular disease, chronic kidney disease, obesity and type 2 diabetes, providing a comprehensive framework for prevention, risk assessment and treatment.
In the perspective, the authors note that while effective therapies for CKM syndrome are increasingly available, major barriers continue to limit adoption. These include gaps in insurance coverage, limited care coordination across specialties, lack of diagnosis codes linked to CKM syndrome stages and challenges related to reimbursement for multidisciplinary care.
The authors highlight the importance of team-based care models that bring together cardiology, nephrology, endocrinology and primary care to address the complex needs of patients with CKM syndrome. They also emphasize the need for health system and policy changes that support coordinated care, improve access to evidence-based therapies and reduce fragmentation across specialties. Looking ahead, the authors suggest that broader adoption of evidence-based therapies, combined with health policy reforms and patient care innovation could help reduce the burden of CKM syndrome on the healthcare system.
The publication accompanies the release of the new national guideline, which was developed jointly by the American Heart Association, American College of Cardiology, American Diabetes Association and American Society of Nephrology. The guideline outlines recommendations for screening, prevention and management of CKM syndrome, a condition that affects the heart, kidneys and metabolic health and is increasingly recognized as a major driver of cardiovascular risk.